Viveve Medical Inc (VIVE) Gross Profit Margin starting from the third quarter 2022 to third quarter 2021, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Viveve Medical Inc   (NASDAQ: VIVE)


Viveve Medical Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VIVE Gross Profit Margin (Sep 30 2022)
Q3 		(Jun 30 2022)
Q2 		(Mar 31 2022)
Q1 		(Dec 31 2021)
Q4 		(Sep 30 2021)
Q3
Y / Y Revenue Change 4.21 %
Seq. Revenue Change -6.18 %
Revenue In Millions $1.68
Gross Profit Margin 32.42 %
Gross Profit Margin Total Ranking # 2646
Gross Profit In Millions $0.55
Y / Y Gross Profit Change 378.95 %
Seq. Gross Profit Change 85.71 %


Commenting Third Quarter 2022 Gross Profit Margin
Viveve Medical Inc achieved Gross Profit of $1 millions compare to Gross Loss of $0.29 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q3 of -6.18 % Viveve Medical Inc managed to reduce Cost of Sales and increase Gross Profit by 85.71 % to $1 millions. Gross Profit Margin grew to 32.42 %, above company average Gross Profit Margin.


Observing third quarter 2022 results within Medical Equipment & Supplies industry 173 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2646, from total ranking in the previous quarter at 3532.
Learn about Gross Margin
VIVE's Gross Profit Margin third quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 174
Healthcare Sector # 451
Overall # 2600

Gross Profit Margin Statistics
High Average Low
67.12 % 31.1 % 7.05 %
(Jun 30 2014)   (Sep 30 2021)


VIVE Gross Income Trends • More of VIVE's Profitabilty Ratios • VIVE Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
VIVE's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
VIVE's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for VIVE's Competitors
Gross Profit Margin Profit Margin for Viveve Medical Inc 's Suppliers
Gross Profit Margin Profit Margin for VIVE's Customers

You may also want to know
VIVE's Annual Growth Rates VIVE's Profitability Ratios VIVE's Asset Turnover Ratio VIVE's Dividend Growth
VIVE's Roe VIVE's Valuation Ratios VIVE's Financial Strength Ratios VIVE's Gross Profit Growth
VIVE's Roa VIVE's Inventory Turnover Ratio VIVE's Growth Rates VIVE's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2022, within Medical Equipment & Supplies Industry Gross Profit MarginSep 30 2022 MRQ Gross ProfitSep 30 2022 MRQ Revenue
Neuraxis Inc   89.08 %$ 0.551  Millions$ 0.619  Millions
Inari Medical Inc   88.50 %$ 85.140  Millions$ 96.204  Millions
Therapeutic Solutions International Inc   88.21 %$ 0.066  Millions$ 0.075  Millions
Electrocore Inc   86.94 %$ 1.718  Millions$ 1.976  Millions
Shockwave Medical Inc   86.39 %$ 113.456  Millions$ 131.330  Millions
Vycor Medical Inc   86.39 %$ 0.268  Millions$ 0.310  Millions
Co diagnostics Inc   84.93 %$ 4.327  Millions$ 5.094  Millions
Sight Sciences Inc   84.32 %$ 15.749  Millions$ 18.677  Millions
Si bone inc   84.23 %$ 22.264  Millions$ 26.432  Millions
Fonar Corporation  83.61 %$ 19.391  Millions$ 23.191  Millions
Axogen inc   83.29 %$ 30.783  Millions$ 36.959  Millions
Avita Medical Inc   83.17 %$ 7.562  Millions$ 9.092  Millions
Nuo Therapeutics Inc   83.02 %$ 0.032  Millions$ 0.038  Millions
Sanara Medtech Inc   82.92 %$ 10.816  Millions$ 13.045  Millions
Cvrx inc   82.89 %$ 4.846  Millions$ 5.846  Millions
Trisalus Life Sciences Inc   82.13 %$ 3.222  Millions$ 3.923  Millions
Mimedx Group Inc   81.99 %$ 55.501  Millions$ 67.689  Millions
Inspire Medical Systems inc   81.88 %$ 89.402  Millions$ 109.188  Millions
Abiomed Inc   81.62 %$ 217.041  Millions$ 265.921  Millions
Paragon 28 inc   81.54 %$ 37.515  Millions$ 46.006  Millions
Edwards Lifesciences Corporation  80.76 %$ 1,065.200  Millions$ 1,319.000  Millions
Treace Medical Concepts Inc   79.96 %$ 26.431  Millions$ 33.055  Millions
Zynex inc   79.79 %$ 33.129  Millions$ 41.520  Millions
Marizyme Inc   79.61 %$ 0.061  Millions$ 0.076  Millions
Staar Surgical Co  79.51 %$ 60.462  Millions$ 76.046  Millions
Electromedical Technologies Inc   79.25 %$ 0.222  Millions$ 0.280  Millions
Oak Street Health Inc   79.18 %$ 432.100  Millions$ 545.700  Millions
Sintx Technologies Inc   79.11 %$ 0.337  Millions$ 0.426  Millions
Iradimed Corporation  78.63 %$ 10.543  Millions$ 13.407  Millions
Surmodics Inc   78.46 %$ 20.391  Millions$ 25.988  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.